nodes	percent_of_prediction	percent_of_DWPC	metapath
Alimemazine—Obstruction—Ifosfamide—testicular cancer	0.175	0.175	CcSEcCtD
Alimemazine—Arrhythmia supraventricular—Ifosfamide—testicular cancer	0.0426	0.0426	CcSEcCtD
Alimemazine—Electrocardiogram ST segment depression—Epirubicin—testicular cancer	0.0322	0.0322	CcSEcCtD
Alimemazine—Electrocardiogram ST segment depression—Doxorubicin—testicular cancer	0.0298	0.0298	CcSEcCtD
Alimemazine—Amenorrhoea—Chlorambucil—testicular cancer	0.0284	0.0284	CcSEcCtD
Alimemazine—Dyskinesia—Chlorambucil—testicular cancer	0.0265	0.0265	CcSEcCtD
Alimemazine—Amenorrhoea—Ifosfamide—testicular cancer	0.0188	0.0188	CcSEcCtD
Alimemazine—Dyskinesia—Ifosfamide—testicular cancer	0.0176	0.0176	CcSEcCtD
Alimemazine—Infection—Carboplatin—testicular cancer	0.0172	0.0172	CcSEcCtD
Alimemazine—Ventricular tachycardia—Ifosfamide—testicular cancer	0.0165	0.0165	CcSEcCtD
Alimemazine—Body temperature increased—Carboplatin—testicular cancer	0.0137	0.0137	CcSEcCtD
Alimemazine—Jaundice—Chlorambucil—testicular cancer	0.0136	0.0136	CcSEcCtD
Alimemazine—Agranulocytosis—Vinblastine—testicular cancer	0.0119	0.0119	CcSEcCtD
Alimemazine—Nasal congestion—Cisplatin—testicular cancer	0.0113	0.0113	CcSEcCtD
Alimemazine—Hypokalaemia—Ifosfamide—testicular cancer	0.0109	0.0109	CcSEcCtD
Alimemazine—Tremor—Chlorambucil—testicular cancer	0.0102	0.0102	CcSEcCtD
Alimemazine—Agitation—Chlorambucil—testicular cancer	0.01	0.01	CcSEcCtD
Alimemazine—Convulsion—Chlorambucil—testicular cancer	0.00945	0.00945	CcSEcCtD
Alimemazine—Orthostatic hypotension—Cisplatin—testicular cancer	0.00943	0.00943	CcSEcCtD
Alimemazine—Agranulocytosis—Dactinomycin—testicular cancer	0.0094	0.0094	CcSEcCtD
Alimemazine—Hypokalaemia—Cisplatin—testicular cancer	0.0094	0.0094	CcSEcCtD
Alimemazine—Infection—Chlorambucil—testicular cancer	0.00884	0.00884	CcSEcCtD
Alimemazine—Convulsion—Vinblastine—testicular cancer	0.00866	0.00866	CcSEcCtD
Alimemazine—Agranulocytosis—Ifosfamide—testicular cancer	0.00861	0.00861	CcSEcCtD
Alimemazine—Amenorrhoea—Epirubicin—testicular cancer	0.00831	0.00831	CcSEcCtD
Alimemazine—Jaundice cholestatic—Epirubicin—testicular cancer	0.00831	0.00831	CcSEcCtD
Alimemazine—Dyskinesia—Epirubicin—testicular cancer	0.00777	0.00777	CcSEcCtD
Alimemazine—Amenorrhoea—Doxorubicin—testicular cancer	0.00769	0.00769	CcSEcCtD
Alimemazine—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00769	0.00769	CcSEcCtD
Alimemazine—Cardiac disorder—Ifosfamide—testicular cancer	0.00769	0.00769	CcSEcCtD
Alimemazine—Atrioventricular block—Epirubicin—testicular cancer	0.00753	0.00753	CcSEcCtD
Alimemazine—Arrhythmia—Ifosfamide—testicular cancer	0.0074	0.0074	CcSEcCtD
Alimemazine—Ventricular tachycardia—Epirubicin—testicular cancer	0.0073	0.0073	CcSEcCtD
Alimemazine—Dyskinesia—Doxorubicin—testicular cancer	0.00719	0.00719	CcSEcCtD
Alimemazine—Jaundice—Etoposide—testicular cancer	0.00711	0.00711	CcSEcCtD
Alimemazine—Body temperature increased—Chlorambucil—testicular cancer	0.00703	0.00703	CcSEcCtD
Alimemazine—Gynaecomastia—Methotrexate—testicular cancer	0.00698	0.00698	CcSEcCtD
Alimemazine—Atrioventricular block—Doxorubicin—testicular cancer	0.00697	0.00697	CcSEcCtD
Alimemazine—Infection—Bleomycin—testicular cancer	0.00684	0.00684	CcSEcCtD
Alimemazine—Agranulocytosis—Etoposide—testicular cancer	0.0068	0.0068	CcSEcCtD
Alimemazine—Ventricular tachycardia—Doxorubicin—testicular cancer	0.00676	0.00676	CcSEcCtD
Alimemazine—Cardiac disorder—Cisplatin—testicular cancer	0.00663	0.00663	CcSEcCtD
Alimemazine—Agitation—Ifosfamide—testicular cancer	0.00663	0.00663	CcSEcCtD
Alimemazine—Photosensitivity—Methotrexate—testicular cancer	0.00645	0.00645	CcSEcCtD
Alimemazine—Hypotension—Bleomycin—testicular cancer	0.00644	0.00644	CcSEcCtD
Alimemazine—Infection—Dactinomycin—testicular cancer	0.00638	0.00638	CcSEcCtD
Alimemazine—Arrhythmia—Cisplatin—testicular cancer	0.00638	0.00638	CcSEcCtD
Alimemazine—Convulsion—Ifosfamide—testicular cancer	0.00625	0.00625	CcSEcCtD
Alimemazine—Cardiac disorder—Etoposide—testicular cancer	0.00607	0.00607	CcSEcCtD
Alimemazine—Photosensitivity—Epirubicin—testicular cancer	0.00604	0.00604	CcSEcCtD
Alimemazine—Infection—Ifosfamide—testicular cancer	0.00585	0.00585	CcSEcCtD
Alimemazine—Tremor—Cisplatin—testicular cancer	0.00583	0.00583	CcSEcCtD
Alimemazine—Nervous system disorder—Ifosfamide—testicular cancer	0.00577	0.00577	CcSEcCtD
Alimemazine—Photosensitivity—Doxorubicin—testicular cancer	0.00559	0.00559	CcSEcCtD
Alimemazine—Hypotension—Ifosfamide—testicular cancer	0.0055	0.0055	CcSEcCtD
Alimemazine—Body temperature increased—Bleomycin—testicular cancer	0.00544	0.00544	CcSEcCtD
Alimemazine—Convulsion—Cisplatin—testicular cancer	0.00539	0.00539	CcSEcCtD
Alimemazine—Body temperature increased—Dactinomycin—testicular cancer	0.00508	0.00508	CcSEcCtD
Alimemazine—Infection—Cisplatin—testicular cancer	0.00504	0.00504	CcSEcCtD
Alimemazine—Nervous system disorder—Cisplatin—testicular cancer	0.00498	0.00498	CcSEcCtD
Alimemazine—Convulsion—Etoposide—testicular cancer	0.00494	0.00494	CcSEcCtD
Alimemazine—Eosinophilia—Methotrexate—testicular cancer	0.00485	0.00485	CcSEcCtD
Alimemazine—Orthostatic hypotension—Epirubicin—testicular cancer	0.00484	0.00484	CcSEcCtD
Alimemazine—Hypokalaemia—Epirubicin—testicular cancer	0.00483	0.00483	CcSEcCtD
Alimemazine—Hypotension—Cisplatin—testicular cancer	0.00474	0.00474	CcSEcCtD
Alimemazine—Body temperature increased—Ifosfamide—testicular cancer	0.00465	0.00465	CcSEcCtD
Alimemazine—Infection—Etoposide—testicular cancer	0.00462	0.00462	CcSEcCtD
Alimemazine—Eosinophilia—Epirubicin—testicular cancer	0.00454	0.00454	CcSEcCtD
Alimemazine—Erectile dysfunction—Methotrexate—testicular cancer	0.00451	0.00451	CcSEcCtD
Alimemazine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00448	0.00448	CcSEcCtD
Alimemazine—Photosensitivity reaction—Methotrexate—testicular cancer	0.00447	0.00447	CcSEcCtD
Alimemazine—Hypokalaemia—Doxorubicin—testicular cancer	0.00446	0.00446	CcSEcCtD
Alimemazine—Hypotension—Etoposide—testicular cancer	0.00434	0.00434	CcSEcCtD
Alimemazine—Rash—Bleomycin—testicular cancer	0.00434	0.00434	CcSEcCtD
Alimemazine—Dermatitis—Bleomycin—testicular cancer	0.00434	0.00434	CcSEcCtD
Alimemazine—Eosinophilia—Doxorubicin—testicular cancer	0.0042	0.0042	CcSEcCtD
Alimemazine—Photosensitivity reaction—Epirubicin—testicular cancer	0.00418	0.00418	CcSEcCtD
Alimemazine—Agranulocytosis—Methotrexate—testicular cancer	0.00407	0.00407	CcSEcCtD
Alimemazine—Rash—Dactinomycin—testicular cancer	0.00405	0.00405	CcSEcCtD
Alimemazine—Body temperature increased—Cisplatin—testicular cancer	0.00401	0.00401	CcSEcCtD
Alimemazine—Jaundice—Epirubicin—testicular cancer	0.00398	0.00398	CcSEcCtD
Alimemazine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00387	0.00387	CcSEcCtD
Alimemazine—Agranulocytosis—Epirubicin—testicular cancer	0.00381	0.00381	CcSEcCtD
Alimemazine—Rash—Ifosfamide—testicular cancer	0.00371	0.00371	CcSEcCtD
Alimemazine—Dermatitis—Ifosfamide—testicular cancer	0.00371	0.00371	CcSEcCtD
Alimemazine—Jaundice—Doxorubicin—testicular cancer	0.00369	0.00369	CcSEcCtD
Alimemazine—Body temperature increased—Etoposide—testicular cancer	0.00368	0.00368	CcSEcCtD
Alimemazine—Cardiac disorder—Methotrexate—testicular cancer	0.00364	0.00364	CcSEcCtD
Alimemazine—Agranulocytosis—Doxorubicin—testicular cancer	0.00353	0.00353	CcSEcCtD
Alimemazine—Cardiac disorder—Epirubicin—testicular cancer	0.0034	0.0034	CcSEcCtD
Alimemazine—Arrhythmia—Epirubicin—testicular cancer	0.00328	0.00328	CcSEcCtD
Alimemazine—Rash—Cisplatin—testicular cancer	0.0032	0.0032	CcSEcCtD
Alimemazine—Dermatitis—Cisplatin—testicular cancer	0.0032	0.0032	CcSEcCtD
Alimemazine—Cardiac disorder—Doxorubicin—testicular cancer	0.00315	0.00315	CcSEcCtD
Alimemazine—Arrhythmia—Doxorubicin—testicular cancer	0.00303	0.00303	CcSEcCtD
Alimemazine—Convulsion—Methotrexate—testicular cancer	0.00296	0.00296	CcSEcCtD
Alimemazine—Agitation—Epirubicin—testicular cancer	0.00293	0.00293	CcSEcCtD
Alimemazine—Rash—Etoposide—testicular cancer	0.00293	0.00293	CcSEcCtD
Alimemazine—Dermatitis—Etoposide—testicular cancer	0.00293	0.00293	CcSEcCtD
Alimemazine—Convulsion—Epirubicin—testicular cancer	0.00277	0.00277	CcSEcCtD
Alimemazine—Infection—Methotrexate—testicular cancer	0.00277	0.00277	CcSEcCtD
Alimemazine—Nervous system disorder—Methotrexate—testicular cancer	0.00273	0.00273	CcSEcCtD
Alimemazine—Agitation—Doxorubicin—testicular cancer	0.00272	0.00272	CcSEcCtD
Alimemazine—Dry mouth—Epirubicin—testicular cancer	0.00266	0.00266	CcSEcCtD
Alimemazine—Hypotension—Methotrexate—testicular cancer	0.0026	0.0026	CcSEcCtD
Alimemazine—Infection—Epirubicin—testicular cancer	0.00259	0.00259	CcSEcCtD
Alimemazine—Convulsion—Doxorubicin—testicular cancer	0.00256	0.00256	CcSEcCtD
Alimemazine—Nervous system disorder—Epirubicin—testicular cancer	0.00256	0.00256	CcSEcCtD
Alimemazine—Insomnia—Methotrexate—testicular cancer	0.00252	0.00252	CcSEcCtD
Alimemazine—Dry mouth—Doxorubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Alimemazine—Hypotension—Epirubicin—testicular cancer	0.00244	0.00244	CcSEcCtD
Alimemazine—Infection—Doxorubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Alimemazine—Nervous system disorder—Doxorubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Alimemazine—Insomnia—Epirubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Alimemazine—Hypotension—Doxorubicin—testicular cancer	0.00225	0.00225	CcSEcCtD
Alimemazine—Body temperature increased—Methotrexate—testicular cancer	0.0022	0.0022	CcSEcCtD
Alimemazine—Insomnia—Doxorubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Alimemazine—Body temperature increased—Epirubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Alimemazine—Body temperature increased—Doxorubicin—testicular cancer	0.00191	0.00191	CcSEcCtD
Alimemazine—Rash—Methotrexate—testicular cancer	0.00176	0.00176	CcSEcCtD
Alimemazine—Dermatitis—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Alimemazine—Rash—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Alimemazine—Dermatitis—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Alimemazine—Rash—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Alimemazine—Dermatitis—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
